Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Topical 5-fluorouracil first choice for treatment of actinic keratosis

    • 1 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Jansen MHE, et al. A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs imiquimod vs ingenol mebutate vs methylaminolevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands. British Journal of Dermatology : 21 Jan 2020. Available from: URL: http://doi.org/10.1111/bjd.18884

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Topical 5-fluorouracil first choice for treatment of actinic keratosis. PharmacoEcon Outcomes News 846, 28 (2020). https://doi.org/10.1007/s40274-020-6567-1

    Download citation